Should therapy be stopped in patients who experience infectious events while on baricitinib?

Featuring Karan Lal, DO, MS, FAAD | Director of Pediatric and Cosmetic DermatologyAffiliated DermatologyScottsdale, AZ | Published October 01, 2024